FDA Previously Granted Rolling Review for BLA VANCOUVER, Washington, Mar 18, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential […]
DENVER, March 21, 2019 -Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, today announced it will be presenting at the Sidoti & Company, LLC, Spring 2019 […]
Boeing Co will install an extra safety alarm in the cockpits of all its 737 MAX aircraft after intense criticism in the wake of two fatal crashes, the Financial Times reported on Thursday.
U.S. stocks eked out gains on Thursday as declines in financial stocks after the Federal Reserve’s move to not raise interest rates this year were countered by gains in technology companies.
Biogen and partner Eisai Co Ltd are ending two late-stage trials for the experimental Alzheimer’s drug aducanumab, in a setback to efforts to find treatments for the disease and for Biogen’s stock, which lost more than $17 billion of its value on Thursday.
Tencent Holdings signaled it will reduce its reliance on gaming in China, where a regulatory review and one-off investment costs led to its sharpest-ever quarterly profit drop and slowest annual profit growth in 13 years.
U.S. stocks opened lower on Thursday, after the Federal Reserve abandoned any interest rate hikes this year and flagged an expected slowdown in the economy.
Biogen and partner Eisai Co Ltd are ending two late-stage trials testing the experimental Alzheimer’s drug aducanumab, marking the latest setback for an industry racing to develop treatments for the memory-robbing disease.
Indonesian investigators described on Thursday the panic of pilots grappling with airspeed and altitude problems in the last moments of their doomed Lion Air flight, as comparisons mounted with a disaster in Ethiopia.
The number of Americans filing applications for unemployment benefits fell more than expected last week, pointing to still strong labor market conditions, though the pace of job growth has slowed after last year’s robust gains.
Euro zone banking watchdogs said banks planning mergers should make sure they could be wound down in a crisis, a warning likely to resonate with executives seeking to merge German giants Deutsche Bank and Commerzbank.
Biogen and partner Eisai Co Ltd are ending two late-stage trials testing an Alzheimer’s drug, they said Thursday, marking the latest setback for an industry keen to develop treatments for the memory-robbing disease.
The number of Americans filing applications for unemployment benefits fell more than expected last week, pointing to still strong labor market conditions, though the pace of job growth has slowed after last year’s robust gains.
Finland’s data protection ombudsman said on Thursday he would investigate whether Nokia-branded phones had breached data rules after a report said the handsets sent information to China.
The European Union watchdog in charge of disposing of failing banks said on Thursday that Deutsche Bank and Commerzbank should make sure any lender emerging from a possible merger could be wound down in case of a crisis.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
